Summary
One of the most exciting and useful advances in nuclear cardiology is the opportunity to measure myocardial blood flow (MBF) routinely as part of myocardial perfusion imaging (MPI) with positron emission tomography (PET). Incorporating MBF into the MPI evaluation improves diagnosis and assessment of extent and severity of epicardial coronary artery disease (CAD), reclassifies prognosis from assessment based solely on perfusion defects, confirms effectiveness of pharmacologic stress, and can identify coronary microvascular disease with or without epicardial CAD. Read more.
Resource Type
Guidelines, Information Statements
Clinical Topic
Cardiac PET, Myocardial Blood Flow (MBF), Myocardial Perfusion Imaging (MPI)
Year Published
2021
Related Resources
PET Case: The Silent Infiltrator: Role of FDG-PET in a Challenging Case of Inflammatory Cardiomyopathy
Case summary: 45-year-old male with no significant past medical history presented with…
PET Case: Perfusion Imaging Using Flurpiridaz F 18 PET
Case summary: This case illustrates the first clinical use of F-18 flurpiridaz…